(FLEX, PGI, BIIB) CRWENewswire Stocks In Action
- 2011/10/22 02:50:31 投稿
- 再生数：30
- マイリスト数：0
According to BIIB, The significant clinical and radiological responses in the trial are further evidence that BG-12 may become an oral therapy of choice for multiple sclerosis patients.